Dawson Laura A, Jaffray David A
Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
J Clin Oncol. 2007 Mar 10;25(8):938-46. doi: 10.1200/JCO.2006.09.9515.
Imaging is central to radiation oncology practice, with advances in radiation oncology occurring in parallel to advances in imaging. Targets to be irradiated and normal tissues to be spared are delineated on computed tomography (CT) scans in the planning process. Computer-assisted design of the radiation dose distribution ensures that the objectives for target coverage and avoidance of healthy tissue are achieved. The radiation treatment units are now recognized as state-of-the-art robotics capable of three-dimensional soft tissue imaging immediately before, during, or after radiation delivery, improving the localization of the target at the time of radiation delivery, to ensure that radiation therapy is delivered as planned. Frequent imaging in the treatment room during a course of radiation therapy, with decisions made on the basis of imaging, is referred to as image-guided radiation therapy (IGRT). IGRT allows changes in tumor position, size, and shape to be measured during the course of therapy, with adjustments made to maximize the geometric accuracy and precision of radiation delivery, reducing the volume of healthy tissue irradiated and permitting dose escalation to the tumor. These geometric advantages increase the chance of tumor control, reduce the risk of toxicity after radiotherapy, and facilitate the development of shorter radiotherapy schedules. By reducing the variability in delivered doses across a population of patients, IGRT should also improve interpretation of future clinical trials.
成像在放射肿瘤学实践中至关重要,放射肿瘤学的进展与成像技术的进步同步发生。在治疗计划过程中,要照射的靶区和要保护的正常组织通过计算机断层扫描(CT)进行勾画。放射剂量分布的计算机辅助设计可确保实现靶区覆盖和避免损伤健康组织的目标。现在,放射治疗设备被认为是先进的机器人设备,能够在放射治疗前、治疗期间或治疗后立即进行三维软组织成像,从而在放射治疗时改善靶区的定位,确保放射治疗按计划进行。在放射治疗疗程中,在治疗室内频繁成像,并根据成像结果做出决策,这被称为图像引导放射治疗(IGRT)。IGRT能够在治疗过程中测量肿瘤位置、大小和形状的变化,并进行调整以最大限度地提高放射治疗的几何精度,减少受照射健康组织的体积,并允许提高肿瘤的照射剂量。这些几何优势增加了肿瘤控制的机会,降低了放疗后毒性反应的风险,并有助于制定更短的放疗方案。通过减少不同患者群体中实际照射剂量的差异,IGRT还应有助于改进未来临床试验的解读。